AU1756483A - Pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives - Google Patents
Pyridinecarboxylic esters of dopamine and of its n-alkyl derivativesInfo
- Publication number
- AU1756483A AU1756483A AU17564/83A AU1756483A AU1756483A AU 1756483 A AU1756483 A AU 1756483A AU 17564/83 A AU17564/83 A AU 17564/83A AU 1756483 A AU1756483 A AU 1756483A AU 1756483 A AU1756483 A AU 1756483A
- Authority
- AU
- Australia
- Prior art keywords
- atoms
- dopamine
- alkyl derivatives
- straight
- branched alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 title 2
- 229960003638 dopamine Drugs 0.000 title 1
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical class OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 208000017169 kidney disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8222761A IT1210918B (it) | 1982-08-06 | 1982-08-06 | Esteri piridincarbossilici della dopamina e suoi alchie derivati |
| IT2276182 | 1982-08-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1756483A true AU1756483A (en) | 1984-02-09 |
Family
ID=11200146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU17564/83A Abandoned AU1756483A (en) | 1982-08-06 | 1983-08-03 | Pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives |
Country Status (12)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU625163B2 (en) * | 1989-09-12 | 1992-07-02 | Mitsui Toatsu Chemicals Inc. | Dihydrocaffeic acid derivatives and pharmaceutical preparations containing same |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5290793A (en) * | 1989-09-12 | 1994-03-01 | Mitsui Toatsu Chemicals, Incorporated | Dihydrocaffeic acid derivatives and pharmaceutical preparation containing same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2428253A (en) * | 1940-03-23 | 1947-09-30 | Werder Fritz Von | Water-soluble derivatives of 2-methyl-1, 4-dihydroxy-naphthalene and processes for their production |
| US3904671A (en) * | 1969-04-01 | 1975-09-09 | Sterling Drug Inc | Esters of 3-(hydroxy or hydroxymethyl)-4-hydroxyphenyl aminomethyl ketones |
-
1982
- 1982-08-06 IT IT8222761A patent/IT1210918B/it active
-
1983
- 1983-08-01 DE DE8383201138T patent/DE3368051D1/de not_active Expired
- 1983-08-01 AT AT83201138T patent/ATE23996T1/de active
- 1983-08-01 EP EP83201138A patent/EP0101633B1/en not_active Expired
- 1983-08-03 IE IE1839/83A patent/IE55647B1/en unknown
- 1983-08-03 AU AU17564/83A patent/AU1756483A/en not_active Abandoned
- 1983-08-04 ZA ZA835743A patent/ZA835743B/xx unknown
- 1983-08-05 ES ES525464A patent/ES8502972A1/es not_active Expired
- 1983-08-05 CA CA000433946A patent/CA1234572A/en not_active Expired
- 1983-08-05 DK DK358283A patent/DK358283A/da not_active Application Discontinuation
- 1983-08-06 JP JP58144334A patent/JPS5962570A/ja active Granted
-
1985
- 1985-02-08 US US06/699,598 patent/US4644004A/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU625163B2 (en) * | 1989-09-12 | 1992-07-02 | Mitsui Toatsu Chemicals Inc. | Dihydrocaffeic acid derivatives and pharmaceutical preparations containing same |
Also Published As
| Publication number | Publication date |
|---|---|
| IE55647B1 (en) | 1990-12-05 |
| ATE23996T1 (de) | 1986-12-15 |
| DE3368051D1 (en) | 1987-01-15 |
| ES525464A0 (es) | 1985-02-01 |
| EP0101633B1 (en) | 1986-12-03 |
| DK358283D0 (da) | 1983-08-05 |
| JPH0434541B2 (enrdf_load_stackoverflow) | 1992-06-08 |
| CA1234572A (en) | 1988-03-29 |
| DK358283A (da) | 1984-02-07 |
| IE831839L (en) | 1984-02-06 |
| US4644004A (en) | 1987-02-17 |
| JPS5962570A (ja) | 1984-04-10 |
| ES8502972A1 (es) | 1985-02-01 |
| ZA835743B (en) | 1984-06-27 |
| IT8222761A0 (it) | 1982-08-06 |
| IT1210918B (it) | 1989-09-29 |
| EP0101633A1 (en) | 1984-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL99889A0 (en) | Azasteroid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| ES8103743A1 (es) | Un metodo para la preparacion de derivados de ftalimidina | |
| CA2036876A1 (fr) | Derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| PT79819A (en) | Process to prepare dihydropiridazinone derivatives its salts and pharmaceutical compositions and intermediate compounds there with | |
| FI883744A0 (fi) | Menetelmä valmistaa farmaseuttisesti käyttökelpoisia indolijohdoksia | |
| NO179638C (no) | Analogifremgangsmåte for fremstilling av tiazolderivater | |
| MA21722A1 (fr) | Derives de 2 - aminopyrimidinones utiles notamment comme antagonistes des neurotransmetteurs et procede pour leur preparation . | |
| DE69008142D1 (de) | 4-Substituierten Imidazolen zur Senkung des intraokularen Druckes. | |
| NZ208691A (en) | Dihydrodibenzocycloheptylidene-ethylpiperazine derivatives and pharmaceutical compositions thereof | |
| IT1169783B (it) | Derivati dell' acido 4-fenil 4-osso-buten 2-oico, loro procedimento di preparazione e loro applicazione come prodotti medicinali | |
| AU1756483A (en) | Pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives | |
| DE3362846D1 (en) | Derivatives of benzo-1,2-thiazine-1,1-dioxide, a process for their preparation and pharmaceutical compositions containing the same | |
| AU539348B2 (en) | 5,6,8,9-tetrahydro-7h-dibenz(d,f)azonine derivatives | |
| NO904708D0 (no) | Fremgangsmaate for fremstilling av derivater av 2-(3-pyridyl)-2-tetrahydrotiopyrankarbotioamid-1-oksid-(1r-2r). | |
| HUT50461A (en) | Process for producing imidazole derivatives inhibiting dopamin-beta-hydroxylase and pharmaceutical compositions comprising such compounds | |
| ATE29133T1 (de) | Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
| ES2058315T3 (es) | Compuestos eficaces contra insuficiencia cerebral. | |
| ES8707505A2 (es) | Mejoras en el objeto de la patente de invencion n.541.911 por procedimiento de obtencion de nuevos derivados de alfa-(alquilaminopropionil)-tiofeno sustituidos en el anillo tiofenico | |
| GB1482380A (en) | Phenylbutazone derivatives | |
| GB8610369D0 (en) | Heterocyclic compounds | |
| MY103509A (en) | Indole derivatives. | |
| ZA846141B (en) | 3-aryl-3-pyrroline derivatives,process for the preparation thereof and their application for controlling cardiac and vascular diseases |